The integration of artificial intelligence (AI) with the life sciences offers tremendous potential benefits to society, but advances in AI biodesign tools also pose significant risks of misuse, with the potential for global consequences.
New report from NTI | bio offers recommendations for urgent actions that leaders within government, industry, the scientific community, and civil society should take to safeguard AI-bio capabilities.
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
Practical solutions for organizations involved in life science research to manage risks and prevent accidents, misuse, and other adverse outcomes stemming from their work.
In a new opinion piece for The Economist, Jaime Yassif makes the case for urgent action to create stronger guardrails for bioscience and biotechnology.
The first comprehensive assessment of global health security capabilities in 195 countries.
Biotechnology innovation now affects nearly every sector of the global economy.
As part of the Biosecurity Innovation and Risk Reduction Initiative, NTI launched a group to develop a Common Mechanism to Prevent Illicit Gene Synthesis
A journal article describing a new trust-based global health security initiative known as CORDS: Connecting Organizations for Regional Disease Surveillance.
